Related Experiment Video
Updated: Aug 2, 2026
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in
Ida M Gether1, Vivian Kliim-Hansen1, Petur T Olafsson1
1Center for Clinical Metabolic Research, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark.
Introduction:
Oxytocin is expressed throughout the small intestine, suggesting a role for oxytocin in postprandial metabolism. Accordingly, single-dose intranasal oxytocin reduces food intake and improves glucose tolerance. We investigated the effects of a continuous intravenous oxytocin infusion on ad libitum food intake, appetite sensations, and postprandial metabolism.
Methods:
In a randomised, placebo-controlled, double-blind, crossover study, overnight fasted participants with obesity underwent two 4.5-hour intravenous infusions of oxytocin (0.2 international units/min) and placebo (saline), respectively, on separate days interposed by a wash-out period of a minimum of seven days. After 60 min of infusion, participants ingested a standardised liquid mixed meal containing 1.5 g paracetamol (for evaluation of gastric emptying). Appetite sensations were assessed by visual analogue scales, and concentrations of plasma glucose as well as glucose and appetite-regulating hormones were measured. After four hours, food intake (primary endpoint) was assessed by an ad libitum meal test.
Results:
Twenty-four individuals (12 women, median age 41.5 (interquartile range (IQR) 28.5;55.3) years, body mass index 36.2 (32.1;37.6) kg/m2, mean glycated haemoglobin 34 ± standard deviation (SD) 3.5 mmol/mol) completed the study. Ad libitum food intake was similar between oxytocin and saline infusions (mean 714 ± SD 382 vs. 707 ± 385 kcal). Compared with placebo, oxytocin did not affect sensations of appetite nor circulating glucose, insulin, C-peptide, glucagon, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide, cholecystokinin, or paracetamol.
Conclusion:
In individuals with obesity, 4.5-hour intravenous infusion of oxytocin causing supraphysiological plasma concentrations of ~400 pg/mL has no effect on ad libitum food intake, appetite sensations, plasma glucose levels, circulating concentrations of glucose and appetite-regulating hormones, or gastric emptying.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:16Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
01:30Regulation of Food Intake
01:02Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...